FutureTech II Acquisition Corp.
FTIIDelisted Jul 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001889450
FutureTech II Acquisition Corp. was delisted on Jul 11, 2025; its insiders filed their last Form 4 on Feb 6, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding FutureTech II Acquisition Corp. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 34 | 42 | +8 |
| Shares | 10.1M | 11.1M | +1.04M (+10.3%) |
| Value | $103.7M | $116.6M | +$12.9M (+12.4%) |
New holders (12)
Institutions that held FutureTech II Acquisition Corp. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 515,300 | $5.40M | 0.00% |
| Nomura Holdings Inc | 291,000 | $3.05M | 0.03% |
| Rivernorth Capital Management, LLC | 145,000 | $1.52M | 0.07% |
| Goldman Sachs Group Inc | 137,000 | $1.43M | 0.00% |
| Rpo LLC | 107,373 | $1.12M | 0.34% |
| Fir Tree Capital Management LP | 85,903 | $898.5K | 0.07% |
| III Capital Management | 80,000 | $837.6K | 0.06% |
| Aristeia Capital LLC | 71,408 | $747.6K | 0.02% |
| K2 Principal Fund, L.P. | 60,000 | $627.0K | 0.17% |
| CSS LLC | 43,958 | $460.2K | 0.03% |
| Prelude Capital Management, LLC | 40,000 | $418.8K | 0.03% |
| Schonfeld Strategic Advisors LLC | 11,046 | $115.6K | 0.00% |
Sold out (4)
Institutions that held FutureTech II Acquisition Corp. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Cowen Investment Management LLC | 150,000 | $1.54M |
| Cohanzick Management, LLC | 31,211 | $320.8K |
| Cubist Systematic Strategies, LLC | 19,464 | $199.5K |
| Ancora Advisors, LLC | 2,000 | $20.0K |